MYCAMINE

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug MYCAMINE contains one active pharmaceutical ingredient (API):

1 Micafungin UNII IS1UP79R56 - MICAFUNGIN SODIUM

Micafungin non-competitively inhibits the synthesis of 1,3-β-D-glucan, an essential component of the fungal cell wall. 1,3-β-D-glucan is not present in mammalian cells. Micafungin exhibits fungicidal activity against most Candida species and prominently inhibits actively growing hyphae of Aspergillus species. Read about Micafungin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MYCAMINE Powder for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J02AX05	Micafungin	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AX Other antimycotics for systemic use
Discover more medicines within J02AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 540300102152212, 540300104155219
Country: CA	Health Products and Food Branch	Identifier(s): 02294222, 02311054
Country: EE	Ravimiamet	Identifier(s): 1381610, 1381621
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08448001, 08448002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 158608, 158619
Country: FR	Base de données publique des médicaments	Identifier(s): 62450342, 63197760
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 137867, 137990
Country: HK	Department of Health Drug Office	Identifier(s): 55160
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7827, 7828
Country: IT	Agenzia del Farmaco	Identifier(s): 038705012, 038705024
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1032175, 1032176
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 91855, 91863
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 16204, 16205
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100187432, 100187580
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W53472001, W53473001
Country: SG	Health Sciences Authority	Identifier(s): 14464P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699043890307, 8699043890314
Country: US	FDA, National Drug Code	Identifier(s): 0469-3211, 0469-3250
Country: ZA	Health Products Regulatory Authority	Identifier(s): 44/20.2.2/0639, 44/20.2.2/0640